Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) mice.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) mice.
Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) mice. Neoplasia. 2012 Sep; 14(9):778-87.
View in:
PubMed
subject areas
Animals
Animals
Anticarcinogenic Agents
Anticarcinogenic Agents
Aspirin
Aspirin
beta Catenin
beta Catenin
Body Weight
Body Weight
Carcinoma in Situ
Carcinoma in Situ
Carcinoma, Pancreatic Ductal
Carcinoma, Pancreatic Ductal
Cell Transformation, Neoplastic
Cell Transformation, Neoplastic
Cyclin D1
Cyclin D1
Cyclooxygenase 2
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Cyclooxygenase 2 Inhibitors
Disease Progression
Disease Progression
Humans
Humans
Integrases
Integrases
Male
Male
Mice
Mice
Mice, Transgenic
Mice, Transgenic
Nitric Oxide Synthase Type II
Nitric Oxide Synthase Type II
Pancreatic Neoplasms
Pancreatic Neoplasms
Proliferating Cell Nuclear Antigen
Proliferating Cell Nuclear Antigen
Proto-Oncogene Proteins c-bcl-2
Proto-Oncogene Proteins c-bcl-2
Proto-Oncogene Proteins p21(ras)
Proto-Oncogene Proteins p21(ras)
Tumor Suppressor Protein p53
Tumor Suppressor Protein p53
authors with profiles
Venkateshwar Rao Chinthalapally